Crossmark

Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?

Crossref DOI link: https://doi.org/10.1186/s13048-018-0393-0

Published Online: 2018-03-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sahin, Hanifi https://orcid.org/0000-0001-8522-9119
Meydanli, Mehmet Mutlu

Sari, Mustafa Erkan

Yalcin, Ibrahim

Çoban, Gonca

Ozkan, Nazlı Topfedaisi

Cuylan, Zeliha Firat

Erdem, Baki

Gungorduk, Kemal

Akbayir, Özgür

Dede, Murat

Salman, Mustafa Coşkun

Güngör, Tayfun

Ayhan, Ali
More Information

Article History

Received: 31 December 2017

Accepted: 26 February 2018

First Online: 5 March 2018

Ethics approval and consent to participate

: The study protocol was approved by the Local Institutional Review Board (Zekai Tahir Burak Women’s Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey, IRB Approval Number:10, Date: Nov 2nd, 2016). All patients provided an informed consent regarding research use of their medical information at admission.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.